PRPH
Diagnostics & Research · Healthcare
CEO, Board Member
2023-06-16–present
Board Member
ProPhase Labs, Inc. (PRPH)Equibles does not estimate personal net worth.
Get an email with a short summary when ProPhase Labs, Inc. publishes a filing, an earnings call transcript or a press release.
Get PRPH alertsTed Karkus is recorded as Board Member at ProPhase Labs, Inc. (PRPH) since June 16, 2023 and CEO at ProPhase Labs, Inc. (PRPH). The newest filing on record that lists Ted Karkus as CEO at ProPhase Labs, Inc. (PRPH) is dated August 15, 2025. ProPhase Labs, Inc. reported in an 8-K filed June 20, 2023 that Ted Karkus was appointed Director, effective June 16, 2023. The proxy statement of ProPhase Labs, Inc. reports total compensation of $2,123,200 for Ted Karkus in fiscal 2024, including a base salary of $675,000. Disclosed compensation is on record for 6 fiscal years. Ted Karkus has spoken on 17 earnings calls across 1 company, most recently for ProPhase Labs, Inc. on May 20, 2025. ProPhase Labs, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at ProPhase Labs, Inc. includes Monica Brady (CFO), Robert A. Morse, Jr. (CFO and Chief Accounting Officer), Steven M. Plumb (CFO) and 7 others.
“Each of the nominees for election to the board of directors was elected to hold office for a one-year term and until their respective successors are elected and qualified by the following votes:”
“Greetings everyone, and thank you for being here today. I'm Ted Karkus, the CEO of ProPhase Labs. I'm quite pleased with our current position compared to where we were six to nine months ago.”
“I always give a shout-out to Renmark to start. We do a virtual non-deal roadshow presentation just like this every month. If you are a new shareholder, I absolutely recommend you sign up with Redmark, and I love updating shareholders.”
“I appreciate everyone joining us today for ProPhase Labs' presentation. This is our second quarter earnings release and review for our shareholders. I need to start with a forward-looking statement.”
“I really appreciate you moderating as always. Big shout out to Renmark. We do virtual non-deal road shows with Renmark approximately once per month.”
“Thank you, Noella, and thank you everyone for joining today for our year-end results presentation, even though we're about to start the second quarter of the following year.”
2023-06-16–present
Start not stated–present
Last confirmed August 15, 2025
PRPH
Diagnostics & Research · Healthcare
CEO, Board Member
2023-06-16–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | ProPhase Labs, Inc. (PRPH) | Chief Executive Officer | $675,000 | $2,123,200 |
| 2023 | ProPhase Labs, Inc. (PRPH) | Chief Executive Officer | $675,000 | $3,367,200 |
| 2022 | ProPhase Labs, Inc. (PRPH) | Chief Executive Officer | $675,000 | $902,200 |
| 2021 | ProPhase Labs, Inc. (PRPH) | Chief Executive Officer | $590,000 | $941,400 |
| 2019 | ProPhase Labs, Inc. (PRPH) | Chairman of the Board and Chief Executive Officer | $125,000 | $249,000 |
| 2018 | ProPhase Labs, Inc. (PRPH) | Chairman of the Board and Chief Executive Officer | $209,672 | $1,889,923 |